By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Privately held Quantiscientifics today said that BioDot will co-market and sell its A2 MicroArray System.

The A2 system allows for multiplexing in a 96-well plate format. The system was initially developed at Beckman Coulter and enables multiplexing of antibodies, peptides, antigens, and biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.